Latham & Watkins
Latham & Watkins offers legal advisory services. The firms practice areas include antitrust, joint ventures and strategic alliances, entertainment and media industry, funds and acquisition vehicles, finance, hotels, resorts, and gaming, out-of-court restructurings, benefits and compensation, controversy practice, exempt organizations, and international tax. Latham & Watkins was founded in 1934 and is headquartered in Los Angeles, California. The firm has additional offices in Boston, Chicago, Frankfurt, Hamburg, Hong Kong, London, Moscow, New Jersey, and New York.
Reynen Court enables law firms and corporate legal departments to speed their adoption of AI and other new technologies. Its platform combines a solution store for legal technology with a powerful control panel that makes it easy to adapt and manage modern cloud-based software applications without having to trust firm or client content to the rapidly growing universe of vertically integrated SaaS providers. The platform also lets firms manage subscriptions and provisioning from one place and provides valuable telemetry and enhanced interoperability between and among third-party applications. The company was founded in 2018 and is headquartered in Amsterdam.
DrizzleX is an IoT-based SaaS platform that reduces water use in apartment buildings by 20-40% or more. Our proprietary IoT micrometers combined with our powerful SaaS dashboard provides customers with real-time actionable information so that they can pinpoint and fix leaks and encourage tenants to conserve water. No other solution is as cost effective, easy to install in any apartment building, and operates reliably for years with zero maintenance.
KYTHERA Biopharmaceuticals, Inc., formerly known as AESTHERx, Inc., was founded in August 2005 and is a privately held biopharmaceutical company located north of Los Angeles in southern California. KYTHERA is focused on science and innovation in aesthetic medicine. This market is expanding rapidly driven by an aging population, increasing discretionary income, and an evolution of patient preference toward restorative and preventative care. The company uses the tools of biotechnology to develop prescription therapeutics for this emerging market.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.